Results 191 to 200 of about 172,168 (267)

BCR-ABL tyrosine kinase [PDF]

open access: yesScience-Business eXchange, 2011
openaire   +1 more source

[Allogeneic hematopoietic stem cell transplantation for the treatment of BCR::ABL-negative neutrophilic myeloid neoplasms: a clinical analysis of 12 cases]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi
Han TT   +11 more
europepmc   +1 more source

3D-QSAR Design of New Bcr-Abl Inhibitors Based on Purine Scaffold and Cytotoxicity Studies on CML Cell Lines Sensitive and Resistant to Imatinib. [PDF]

open access: yesPharmaceuticals (Basel)
Cabezas D   +13 more
europepmc   +1 more source

Targeted Degradation of SOS1 Exhibits Potent Anticancer Activity and Overcomes Resistance in KRAS-Mutant Tumors and BCR-ABL-Positive Leukemia. [PDF]

open access: yesCancer Res
Luo Z   +15 more
europepmc   +1 more source

Unveiling the nephrotoxic profile of BCR-ABL tyrosine kinase inhibitors: A real-world experience in Africa. [PDF]

open access: yesEJHaem
Ayalew ZS   +8 more
europepmc   +1 more source

CDK8/19 inhibition attenuates G1 arrest induced by BCR-ABL antagonists and accelerates death of chronic myelogenous leukemia cells. [PDF]

open access: yesCell Death Discov
Khamidullina AI   +17 more
europepmc   +1 more source

Co-Occurrence of Jak2-Positive Myelofibrosis and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib. [PDF]

open access: yesMediterr J Hematol Infect Dis
Paciaroni K   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy